Senior insider sale
Chief Medical Officer at JADE BIOSCIENCES, INC. — senior position signals high conviction
$767.4K
30K shares
What this filing means
GILLIES HUNTER plans to sell 30K shares of JADE BIOSCIENCES, INC. valued at approximately $767.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/13/2024ACC: 0001950047-24-004730
Officer· Chief Medical Officer
Since Jun 2021
30K
Shares to sell
$767.4K
Approx. market value
6K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/13/2024
6KTotal acquired6K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/13/2024 | Stock Option Exercise Cash | 6K | — |
| Total | 6K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
4K
Market value
$84.3K
5/17/2024
—Completed
Units to sell
4K
Market value
$89.5K
4/17/2024
—Completed
Units to sell
9K
Market value
$265.5K
3/28/2024
—Completed
Units to sell
3K
Market value
$77.7K
3/18/2024
—Completed
Units to sell
4K
Market value
$103.4K
3/18/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
6K
Market value
$147.0K
6/13/2024
Total
Units
30K
Value
$767.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/17/2024 | 4K | $84.3K | — | Completed |
4/17/2024 | 4K | $89.5K | — | Completed |
3/28/2024 | 9K | $265.5K | — | Completed |
3/18/2024 | 3K | $77.7K | — | Completed |
3/18/2024 | 4K | $103.4K | — | Completed |
| Planned — Approximate Date | ||||
6/13/2024 | 6K | $147.0K | NASDAQ | Planned |
| Total | 30K | $767.4K | ||